As a result, a more robust immune activation was achieved, leading to increased type I interferon-related gene expression and T cell infiltration, turning the “cold” tumor microenvironment into “hot” and, thus, restoring sensitivity to PD-L1 immunotherapy [98]. Here, CD274 is linked to neoplasm.